arrow
N

Nejat Özgül

Department of Obstetrics and Gynecology
H指数:16
被引数:976

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concomitant Metabolic Bariatric Surgery and Minimally Invasive Hysterectomy for Endometrial Cancer or Endometrial Intraepitelhelial Neoplasia in Patients with Severe Obesity: A Systematic Review of Early Experience

同期代谢减重手术与微创子宫切除术治疗重度肥胖患者子宫内膜癌或子宫内膜上皮内瘤变:早期经验的系统评价

2026-07-210
PRE
Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After Recurrence

成人颗粒细胞瘤的复发:影响二次复发及复发后生存的因素

2026-01-010
PRE
Intermediate-risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapy

影响未接受辅助治疗 FIGO 2018 分期 IB2 期宫颈癌患者肿瘤学预后的中危因素

2025-04-230
OA
Patient-Reported Outcomes In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Chemotherapy Plus Dostarlimab Or Placebo In The ENGOT-EN6-NSGO/GOG3031/RUBY Trial Over 3 Years Of Follow-Up

ENGOT-EN6-NSGO/GOG3031/RUBY试验中,接受化疗联合Dostarlimab或安慰剂治疗的原发性晚期或复发性子宫内膜癌患者三年随访的结局报告

2025-02-010
PRE
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study

2023年FIGO分期IIB期子宫内膜癌患者中,辅助治疗和危险因素对生存的影响:土耳其妇科肿瘤学组研究

2024-09-010
PRE
Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone
2017-01-0117
OAAI
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study

手术分期的非侵入性子宫透明细胞癌的预后因素和治疗结果: 土耳其妇科肿瘤学组研究

2017-01-0112
OAAI